MWNA
WGS icon

Marshall Wace North America’s GeneDx Holdings WGS Stock Holding History

Marshall Wace North America’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,924
Closed -$1.81M – 1752
2021
Q2 		$1.81M Hold
3,924
– – 0.01% 839
2021
Q1 		$1.93M Buy
+3,924
New +$2.04M 0.01% 839

Other funds holding WGS

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SM
SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace North America's WGS Position: Q3 2021 in Review

Marshall Wace North America sold out of GeneDx Holdings (WGS) in Q3 2021, closing a stake of 3,924 shares — an estimated $1.81M sold.

Marshall Wace North America first reported a position in WGS in Q1 2021 and held it in 2 quarters. The position peaked at $1.93M in Q1 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q3 2021.

  • Marshall Wace North America reported no remaining GeneDx Holdings position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 3,924 GeneDx Holdings shares in Q3 2021, an estimated $1.81M.
  • Marshall Wace North America first reported a position in GeneDx Holdings in Q1 2021 and held it in 2 quarters.
  • Marshall Wace North America's GeneDx Holdings position peaked at $1.93M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.